The Future of Genome Editing with Professor David Liu

TL;DR

Gene editing technologies such as base editing, prime editing, and proteome editing offer promising solutions for curing diseases and improving human health.

Transcript

welcome to fyi the four-year innovation podcast this show offers an intellectual discussion on technologically enabled disruption because investing in innovation starts with understanding it to learn more visit arc dash invest dot com arc invest is a registered investment advisor focused on investing in disruptive innovation this podcast is for inf... Read More

Key Insights

• 💅 Gene editing technologies like base editing and prime editing have the potential to cure genetic diseases and significantly improve patients' health outcomes.
• 👶 The field of gene editing is rapidly advancing, with continuous progress in developing new and more precise methods for altering DNA sequences.
• ⌛ The cost of gene editing therapies is expected to decrease over time, making them more accessible to a larger population.
• 😷 Proteome editing is an exciting frontier in medical research, with the potential to selectively modify proteins and target specific diseases or biological processes.
• ❓ Collaboration between academia and industry is essential for translating scientific discoveries into effective gene editing therapies.
• 🥺 The next decade is likely to see multiple gene editing therapies approved and commercialized, leading to significant advancements in patient care.
• 👶 The full potential of gene editing is yet to be realized, and ongoing research and innovation will continue to unveil new possibilities for improving human health.

Questions & Answers

Q: What is gene editing, and why is it significant?

Gene editing is a technique that allows for precise modifications of DNA, offering potential cures for genetic diseases. It is significant because it holds the promise of curing diseases that were once considered incurable, such as sickle cell anemia and beta thalassemia.

Q: What are base editing and prime editing, and how do they differ?

Base editing involves making specific changes to individual DNA bases, such as converting a C to a T or an A to a G. Prime editing, on the other hand, allows for more extensive and precise changes in DNA sequences, including insertions, deletions, and changes in multiple bases.

Q: How can gene editing therapies be made more affordable and accessible?

The cost of gene editing therapies is expected to decline over time, thanks to advancements in technology, increased efficiency, and economies of scale. The goal is to make these therapies more democratized and accessible to a wider range of patients.

Q: What is proteome editing, and how could it revolutionize medicine?

Proteome editing involves modifying specific proteins to target diseases or biological processes. It has the potential to revolutionize medicine by selectively manipulating protein functions, which could lead to new treatments for a wide range of conditions, including neurodegenerative diseases and immune-related disorders.

Summary & Key Takeaways

• Gene editing, specifically base editing, has the potential to cure diseases like sickle cell anemia and beta thalassemia, with the number of gene therapy and editing trials increasing significantly in recent years.

• Dr. David Liu, a renowned scientist, inventor, and co-founder of companies like Editas Medicine and Prime Medicine, discusses the advancements in gene editing and the potential of technologies like base editing and prime editing.

• Prime editing, a newer technique, allows for more precise and extensive changes in DNA sequences, offering possibilities for correcting a wider range of genetic mutations.

• Proteome editing, a cutting-edge field, enables the modification of proteins to target specific diseases and processes, offering potential breakthroughs in neuroregeneration, inflammation management, and more.